Marc Lesnick, PhD
SVP, Regulatory and Quality
Marc Lesnick, PhD, officially joins us as the SVP, Regulatory & Quality reporting to the CEO. Based in Knoxville, Marc joins us with over 20 years of pharmaceutical development in the US, EU and Canada. Most recently, Marc co-founded Park Therapeutics, where he assisted in the development of the clinical program for a novel pain drug including the design of Phase 3 pivotal studies and regulatory strategy. Prior work in antibiotics included development of Fetroja® and Dificid® at Shionogi, Inc. and Optimer Pharmaceuticals, respectively. Marc received his PhD in Molecular Biology from the University of Oregon, and performed post-doctoral work in infectious disease at the University of California, San Diego School of Medicine. At Peptilogics, Marc will lend his expertise in creating regulatory and quality strategies as we advance our assets.